MICHAEL JOHNSON to Immunosuppressive Agents
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Immunosuppressive Agents.
Connection Strength
0.073
-
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484.
Score: 0.039
-
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450.
Score: 0.034